Other Authors [124] evaluated different predictive/prognostic factors, namely HER2, Ki-67, thymidine phosphorylase (TP), VEGF and VEGFR expression in the tumor samples of 62 patients with metastatic breast cancer treated with oral CTX and MTX: only, TP was found to be associated with PFS. This evidence concerns the gene VEGFA and neoplasm.